George F. Odland Professor and Head, University of Washington Dermatology, Skin Oncology at Seattle Cancer Care Alliance, University of WA, Fred Hutchinson Cancer Research Center
Dermatology
Dr. Paul T. Nghiem, MD
Paul T. Nghiem, MD is an expert in the field of Dermatology. He researched medicine at Stanford University School of Medicine. Stanford University School of Medicine is a one of the best medicals schools. Stanford University School of Medicine is ranked 2/25 in Research/PrimaryCare. He over the years received 4 awards: "America's Top Doctors", "America's Top Doctors for Cancer", "Fellow (FAAD)" and "Whos Who in Medicine and Healthcare". Doctor Paul T. Nghiem, MD is also published. He has 24 publications published. The lastest publication: "Identification of ATR-Chk1 pathway inhibitors that selectively target p53-deficient cells without directly suppressing ATR catalytic activity.' He accepts all Medicare patients.
Publications
- Identification of ATR-Chk1 pathway inhibitors that selectively target p53-deficient Cells without directly suppressing ATR catalytic activity.
- Milestones in the staging, classification, and biology of merkel Cell carcinoma.
- Dermatofibrosarcoma protuberans, version 1.2014.
- Effect of Host, Tumor, Diagnostic, and Treatment Variables on Outcomes in a Large Cohort With Merkel Cell Carcinoma.
- Relationships among primary tumor size, number of involved nodes, and survival for 8044 cases of Merkel Cell carcinoma.
- Pathogen-driven Cancers and emerging immune therapeutic strategies.
- Regression of metastatic Merkel Cell carcinoma following transfer of polyomavirus-specific T Cells and therapies capable of re-inducing HLA class-I.
- Clinical utility of a circulating tumor Cell assay in Merkel Cell carcinoma.
- p63 Expression in Merkel Cell Carcinoma Predicts Poorer Survival yet May Have Limited Clinical Utility.
- Pathologic nodal evaluation is increasingly commonly performed for patients with Merkel Cell carcinoma.
- Merkel polyomavirus-specific T Cells fluctuate with Merkel Cell carcinoma burden and express therapeutically targetable PD-1 and Tim-3 exhaustion markers.
- Systemic immune suppression predicts diminished Merkel Cell carcinoma-specific survival independent of stage.
- Emerging and Mechanism-Based Therapies for Recurrent or Metastatic Merkel Cell Carcinoma.
- Vascular E-selectin expression correlates with CD8 lymphocyte infiltration and improved outcome in Merkel Cell carcinoma.
- Inhibition of UVB-induced nonmelanoma Skin cancer: a path from tea to caffeine to exercise to decreased tissue fat.
- Array-CGH reveals recurrent genomic changes in Merkel Cell carcinoma including amplification of L-Myc.
- Protection from UV-induced Skin carcinogenesis by genetic inhibition of the ataxia telangiectasia and Rad3-related (ATR) kinase.
- Chemical methodology as a source of small-molecule checkpoint inhibitors and heat shock protein 70 (Hsp70) modulators.
- The protective role of a small GTPase RhoE against UVB-induced DNA damage in keratinocytes.
- Activation of the ATR-mediated DNA damage response by the HIV-1 viral protein R.
- ATR is not required for p53 activation but synergizes with p53 in the replication checkpoint.
- Antisense oligodeoxynucleotides to the cystic fibrosis transmembrane conductance regulator inhibit cAMP-activated but not calcium-activated chloride currents.
- Human lymphocytes transcribe the cystic fibrosis transmembrane conductance regulator gene and exhibit CF-defective cAMP-regulated chloride current.
Schools
Stanford University
Brigham and Womens Hospital
Mass Genl Hospital
Harvard University
Procedures Preformed
- Destruction of Benign Skin Lesion
- Shaving of Skin Lesion
- Skin Tag Removal
Conditions Treated
- Actinic Keratosis
- Atopic Dermatitis (Eczema)
- Basal Cell Carcinoma
- Benign Skin Lesion
- View All
Doctors Specialties
- Dermatology
Accepted Insurances
Awards
- America's Top Doctors
- America's Top Doctors for Cancer
- Fellow (FAAD)
- Whos Who in Medicine and Healthcare
Education
-
Stanford University School of Medicine
Hospital
-
University of Washington Medical Center
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1407932205 |
| Last Name Of The Provider | NGHIEM |
| First Name Of The Provider | PAUL |
| View All |
Similar Doctors
|
Dr. John E. Olerud, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sylvia C. Johnson, MD |
|
|
Dr. Clive M. Liu, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Peter J. Jenkin, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Laura K. Morrison, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Gina P. Kwon, MD |
|
Dr. Jodie S. Reinertson, MD |
|
|
Dr. Christina M. Wahlgren, MD
This Doctor is OpenDoctor Recommended.
|